Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12-03

AUTHORS

Piotr B. Heczko, Anna Tomusiak, Paweł Adamski, Artur J. Jakimiuk, Grzegorz Stefański, Aleksandra Mikołajczyk-Cichońska, Magdalena Suda-Szczurek, Magdalena Strus

ABSTRACT

BackgroundThis multicentre, randomised, double-blind, placebo-controlled trial was performed to determine whether the use of oral probiotic preparation (prOVag®) containing three Lactobacillus strains together with standard metronidazole treatment and also targeted antibiotic treatment (following the failure of metronidazole therapy) could reduce the recurrence rates of bacterial vaginosis (BV) and aerobic vaginitis (AV).MethodsPatients at private gynaecological clinics in Poland with histories of recurrent BV/AV and current symptoms were randomly allocated to receive metronidazole and probiotic or placebo, and assessed monthly on visits II and III-V. The total number of study visits was 5–6 (I, II, II bis – if applicable, III, IV, V). One probiotic or placebo capsule was administered with metronidazole/targeted antibiotic twice daily for 10 days; during follow up, patients took one capsule daily for 10 days perimenstrually. Clinical examination and vaginal swabbing were performed at each visit. Primary outcomes were clinical or microbiological BV/AV recurrence and probiotic safety. Secondary outcomes were vaginal pH, Nugent score, and Lactobacillus counts in the vaginal microbiota. Safety analysis was performed in 578 (probiotic, n = 285; placebo, n = 293) 18–50-year-old women who were randomised.ResultsBV/AV was confirmed microbiologically in 241 (probiotic, n = 118; placebo, n = 123) participants, who continued the trial. Data from 154 (probiotic, n = 73; placebo, n = 81) participants who completed the study were analysed to determine the efficacy of prOVag. Additional analyses included 37 (probiotic, n = 22; placebo, n = 15) participants who received targeted antibiotics and probiotics or placebo. prOVag lengthened the time to clinical relapse of BV/AV symptoms up to 51 % (p < 0.05) compared with placebo; AV relapse was delayed by up to 76 % (p < 0.05). Probiotic use also reduced and maintained low vaginal pH and Nugent score, and increased vaginal Lactobacillus counts following standard treatment.ConclusionThis study demonstrated that oral probiotics lengthened remission in patients with recurrent BV/AV and improved clinical and microbiological parameters.Trial registrationNCT01993524; 20 November 2013. More... »

PAGES

115

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12905-015-0246-6

DOI

http://dx.doi.org/10.1186/s12905-015-0246-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009876367

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26635090


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Intravaginal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Bacterial Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Supplements", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metronidazole", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Poland", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Probiotics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vagina", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vaginosis, Bacterial", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Chair of Microbiology, Jagiellonian University Medical College, Krakow, Poland", 
          "id": "http://www.grid.ac/institutes/grid.5522.0", 
          "name": [
            "Chair of Microbiology, Jagiellonian University Medical College, Krakow, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Heczko", 
        "givenName": "Piotr B.", 
        "id": "sg:person.01116334754.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116334754.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chair of Microbiology, Jagiellonian University Medical College, Krakow, Poland", 
          "id": "http://www.grid.ac/institutes/grid.5522.0", 
          "name": [
            "Chair of Microbiology, Jagiellonian University Medical College, Krakow, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomusiak", 
        "givenName": "Anna", 
        "id": "sg:person.01211122374.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211122374.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Nature Conservation, Polish Academy of Sciences, Krakow, Poland", 
          "id": "http://www.grid.ac/institutes/grid.450925.f", 
          "name": [
            "Institute of Nature Conservation, Polish Academy of Sciences, Krakow, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adamski", 
        "givenName": "Pawe\u0142", 
        "id": "sg:person.01050221554.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050221554.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Reproductive Health Research Institute of Mother and Child, Warsaw, Poland", 
          "id": "http://www.grid.ac/institutes/grid.418838.e", 
          "name": [
            "Clinical Department of Obstetrics and Gynecology, Central Clinical Hospital of Ministry of Interior and Administration, Warsaw, Poland", 
            "Department of Reproductive Health Research Institute of Mother and Child, Warsaw, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jakimiuk", 
        "givenName": "Artur J.", 
        "id": "sg:person.0762122263.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762122263.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IBSS BIOMED S.A, Krakow, Poland", 
          "id": "http://www.grid.ac/institutes/grid.460350.4", 
          "name": [
            "IBSS BIOMED S.A, Krakow, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stefa\u0144ski", 
        "givenName": "Grzegorz", 
        "id": "sg:person.01274562631.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274562631.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IBSS BIOMED S.A, Krakow, Poland", 
          "id": "http://www.grid.ac/institutes/grid.460350.4", 
          "name": [
            "IBSS BIOMED S.A, Krakow, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miko\u0142ajczyk-Cicho\u0144ska", 
        "givenName": "Aleksandra", 
        "id": "sg:person.016617457130.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016617457130.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "IBSS BIOMED S.A, Krakow, Poland", 
          "id": "http://www.grid.ac/institutes/grid.460350.4", 
          "name": [
            "IBSS BIOMED S.A, Krakow, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Suda-Szczurek", 
        "givenName": "Magdalena", 
        "id": "sg:person.0617271731.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617271731.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chair of Microbiology, Jagiellonian University Medical College, Krakow, Poland", 
          "id": "http://www.grid.ac/institutes/grid.5522.0", 
          "name": [
            "Chair of Microbiology, Jagiellonian University Medical College, Krakow, Poland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strus", 
        "givenName": "Magdalena", 
        "id": "sg:person.01013146401.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013146401.27"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1472-6874-8-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005792714", 
          "https://doi.org/10.1186/1472-6874-8-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1177/1933719111418379", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064079117", 
          "https://doi.org/10.1177/1933719111418379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00404-014-3525-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015118061", 
          "https://doi.org/10.1007/s00404-014-3525-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12-03", 
    "datePublishedReg": "2015-12-03", 
    "description": "BackgroundThis multicentre, randomised, double-blind, placebo-controlled trial was performed to determine whether the use of oral probiotic preparation (prOVag\u00ae) containing three Lactobacillus strains together with standard metronidazole treatment and also targeted antibiotic treatment (following the failure of metronidazole therapy) could reduce the recurrence rates of bacterial vaginosis (BV) and aerobic vaginitis (AV).MethodsPatients at private gynaecological clinics in Poland with histories of recurrent BV/AV and current symptoms were randomly allocated to receive metronidazole and probiotic or placebo, and assessed monthly on visits II and III-V. The total number of study visits was 5\u20136 (I, II, II bis \u2013 if applicable, III, IV, V). One probiotic or placebo capsule was administered with metronidazole/targeted antibiotic twice daily for 10\u00a0days; during follow up, patients took one capsule daily for 10\u00a0days perimenstrually. Clinical examination and vaginal swabbing were performed at each visit. Primary outcomes were clinical or microbiological BV/AV recurrence and probiotic safety. Secondary outcomes were vaginal pH, Nugent score, and Lactobacillus counts in the vaginal microbiota. Safety analysis was performed in 578 (probiotic, n\u2009=\u2009285; placebo, n\u2009=\u2009293) 18\u201350-year-old women who were randomised.ResultsBV/AV was confirmed microbiologically in 241 (probiotic, n\u2009=\u2009118; placebo, n\u2009=\u2009123) participants, who continued the trial. Data from 154 (probiotic, n\u2009=\u200973; placebo, n\u2009=\u200981) participants who completed the study were analysed to determine the efficacy of prOVag. Additional analyses included 37 (probiotic, n\u2009=\u200922; placebo, n\u2009=\u200915) participants who received targeted antibiotics and probiotics or placebo. prOVag lengthened the time to clinical relapse of BV/AV symptoms up to 51\u00a0% (p\u2009<\u20090.05) compared with placebo; AV relapse was delayed by up to 76\u00a0% (p\u2009<\u20090.05). Probiotic use also reduced and maintained low vaginal pH and Nugent score, and increased vaginal Lactobacillus counts following standard treatment.ConclusionThis study demonstrated that oral probiotics lengthened remission in patients with recurrent BV/AV and improved clinical and microbiological parameters.Trial registrationNCT01993524; 20 November 2013.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12905-015-0246-6", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1028438", 
        "issn": [
          "1472-6874"
        ], 
        "name": "BMC Women's Health", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "placebo-controlled trial", 
      "aerobic vaginitis", 
      "bacterial vaginosis", 
      "vaginal pH", 
      "oral probiotics", 
      "Nugent score", 
      "Lactobacillus counts", 
      "oral probiotic preparation", 
      "low vaginal pH", 
      "standard antibiotic therapy", 
      "gynaecological clinic", 
      "placebo capsules", 
      "clinical relapse", 
      "metronidazole treatment", 
      "Secondary outcomes", 
      "primary outcome", 
      "antibiotic therapy", 
      "recurrence rate", 
      "standard treatment", 
      "clinical examination", 
      "antibiotic treatment", 
      "study visit", 
      "metronidazole/", 
      "vaginal microbiota", 
      "current symptoms", 
      "probiotic use", 
      "vaginal swabbing", 
      "ConclusionThis study", 
      "probiotic safety", 
      "placebo", 
      "visit II", 
      "trials", 
      "probiotic preparation", 
      "relapse", 
      "vaginosis", 
      "vaginitis", 
      "patients", 
      "probiotics", 
      "Lactobacillus strains", 
      "treatment", 
      "visits", 
      "outcomes", 
      "scores", 
      "participants", 
      "capsule", 
      "count", 
      "total number", 
      "days", 
      "multicentre", 
      "MethodsPatients", 
      "remission", 
      "recurrence", 
      "clinic", 
      "therapy", 
      "symptoms", 
      "metronidazole", 
      "supplementation", 
      "Additional analyses", 
      "women", 
      "efficacy", 
      "antibiotics", 
      "microbiota", 
      "examination", 
      "study", 
      "swabbing", 
      "safety", 
      "safety analysis", 
      "use", 
      "history", 
      "microbiological parameters", 
      "rate", 
      "analysis", 
      "strains", 
      "data", 
      "number", 
      "time", 
      "preparation", 
      "pH", 
      "Poland", 
      "parameters"
    ], 
    "name": "Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial", 
    "pagination": "115", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009876367"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12905-015-0246-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26635090"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12905-015-0246-6", 
      "https://app.dimensions.ai/details/publication/pub.1009876367"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_674.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12905-015-0246-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12905-015-0246-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12905-015-0246-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12905-015-0246-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12905-015-0246-6'


 

This table displays all metadata directly associated to this object as RDF triples.

263 TRIPLES      21 PREDICATES      121 URIs      110 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12905-015-0246-6 schema:about N05c2d1d322094535a119f2e3a152e730
2 N09764d63735545fc824dd571eff79ef4
3 N217293f9bd1241b099c2fcb15bc1728e
4 N51aa9a8bfe844ad7ae163b95e17e0624
5 N68a1135a4c614c5bbc486dedbfc205eb
6 N6945d7a409fb40d3bb19f878ab0ee8f1
7 N7eaae19f145441cd8177c6f40fc88fc1
8 N8ad16a88e67b41a4a03574723033127f
9 N9705ac99117a4d4e819d39025aa36fac
10 Nabc1676f6191440e9880174d1c49ba29
11 Nde0ddf1f094346d9840e6b0596d1ef49
12 Ne540c27602b2478489550d5d293289d5
13 Nf92a59386b4244f6b38c3ce5697d3e92
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author Nde7bfab0411043f890f8a408bd56ba7f
17 schema:citation sg:pub.10.1007/s00404-014-3525-9
18 sg:pub.10.1177/1933719111418379
19 sg:pub.10.1186/1472-6874-8-3
20 schema:datePublished 2015-12-03
21 schema:datePublishedReg 2015-12-03
22 schema:description BackgroundThis multicentre, randomised, double-blind, placebo-controlled trial was performed to determine whether the use of oral probiotic preparation (prOVag®) containing three Lactobacillus strains together with standard metronidazole treatment and also targeted antibiotic treatment (following the failure of metronidazole therapy) could reduce the recurrence rates of bacterial vaginosis (BV) and aerobic vaginitis (AV).MethodsPatients at private gynaecological clinics in Poland with histories of recurrent BV/AV and current symptoms were randomly allocated to receive metronidazole and probiotic or placebo, and assessed monthly on visits II and III-V. The total number of study visits was 5–6 (I, II, II bis – if applicable, III, IV, V). One probiotic or placebo capsule was administered with metronidazole/targeted antibiotic twice daily for 10 days; during follow up, patients took one capsule daily for 10 days perimenstrually. Clinical examination and vaginal swabbing were performed at each visit. Primary outcomes were clinical or microbiological BV/AV recurrence and probiotic safety. Secondary outcomes were vaginal pH, Nugent score, and Lactobacillus counts in the vaginal microbiota. Safety analysis was performed in 578 (probiotic, n = 285; placebo, n = 293) 18–50-year-old women who were randomised.ResultsBV/AV was confirmed microbiologically in 241 (probiotic, n = 118; placebo, n = 123) participants, who continued the trial. Data from 154 (probiotic, n = 73; placebo, n = 81) participants who completed the study were analysed to determine the efficacy of prOVag. Additional analyses included 37 (probiotic, n = 22; placebo, n = 15) participants who received targeted antibiotics and probiotics or placebo. prOVag lengthened the time to clinical relapse of BV/AV symptoms up to 51 % (p < 0.05) compared with placebo; AV relapse was delayed by up to 76 % (p < 0.05). Probiotic use also reduced and maintained low vaginal pH and Nugent score, and increased vaginal Lactobacillus counts following standard treatment.ConclusionThis study demonstrated that oral probiotics lengthened remission in patients with recurrent BV/AV and improved clinical and microbiological parameters.Trial registrationNCT01993524; 20 November 2013.
23 schema:genre article
24 schema:isAccessibleForFree true
25 schema:isPartOf N4ab2cb98b82a47d8aba90a4e1151c167
26 N58253412b4c64f37a5f22d44b4be14ee
27 sg:journal.1028438
28 schema:keywords Additional analyses
29 ConclusionThis study
30 Lactobacillus counts
31 Lactobacillus strains
32 MethodsPatients
33 Nugent score
34 Poland
35 Secondary outcomes
36 aerobic vaginitis
37 analysis
38 antibiotic therapy
39 antibiotic treatment
40 antibiotics
41 bacterial vaginosis
42 capsule
43 clinic
44 clinical examination
45 clinical relapse
46 count
47 current symptoms
48 data
49 days
50 efficacy
51 examination
52 gynaecological clinic
53 history
54 low vaginal pH
55 metronidazole
56 metronidazole treatment
57 metronidazole/
58 microbiological parameters
59 microbiota
60 multicentre
61 number
62 oral probiotic preparation
63 oral probiotics
64 outcomes
65 pH
66 parameters
67 participants
68 patients
69 placebo
70 placebo capsules
71 placebo-controlled trial
72 preparation
73 primary outcome
74 probiotic preparation
75 probiotic safety
76 probiotic use
77 probiotics
78 rate
79 recurrence
80 recurrence rate
81 relapse
82 remission
83 safety
84 safety analysis
85 scores
86 standard antibiotic therapy
87 standard treatment
88 strains
89 study
90 study visit
91 supplementation
92 swabbing
93 symptoms
94 therapy
95 time
96 total number
97 treatment
98 trials
99 use
100 vaginal microbiota
101 vaginal pH
102 vaginal swabbing
103 vaginitis
104 vaginosis
105 visit II
106 visits
107 women
108 schema:name Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial
109 schema:pagination 115
110 schema:productId N04bb39fefcdf4062b186b2a0e51d989f
111 Nae3f7ad5189348a7a34d032aa2d90509
112 Nf3c97ab4891c48b99fc08e3825d1faa7
113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009876367
114 https://doi.org/10.1186/s12905-015-0246-6
115 schema:sdDatePublished 2022-09-02T15:58
116 schema:sdLicense https://scigraph.springernature.com/explorer/license/
117 schema:sdPublisher N0e9777f677b944c298a3106882b7bcb2
118 schema:url https://doi.org/10.1186/s12905-015-0246-6
119 sgo:license sg:explorer/license/
120 sgo:sdDataset articles
121 rdf:type schema:ScholarlyArticle
122 N04bb39fefcdf4062b186b2a0e51d989f schema:name dimensions_id
123 schema:value pub.1009876367
124 rdf:type schema:PropertyValue
125 N05c2d1d322094535a119f2e3a152e730 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Vagina
127 rdf:type schema:DefinedTerm
128 N09764d63735545fc824dd571eff79ef4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Administration, Intravaginal
130 rdf:type schema:DefinedTerm
131 N0af7d5b179034dbbbfff524871f81f4d rdf:first sg:person.016617457130.93
132 rdf:rest Nf5c649e594fd4cd6951772844f5f4940
133 N0e9777f677b944c298a3106882b7bcb2 schema:name Springer Nature - SN SciGraph project
134 rdf:type schema:Organization
135 N217293f9bd1241b099c2fcb15bc1728e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Metronidazole
137 rdf:type schema:DefinedTerm
138 N2f60805c95434e3da9da79be6af7fa96 rdf:first sg:person.01211122374.17
139 rdf:rest Nb28cde1b42c846c892ddcb5828b163e2
140 N42655da94d7040bcbe4a86306f0439f9 rdf:first sg:person.01274562631.03
141 rdf:rest N0af7d5b179034dbbbfff524871f81f4d
142 N4ab2cb98b82a47d8aba90a4e1151c167 schema:issueNumber 1
143 rdf:type schema:PublicationIssue
144 N51aa9a8bfe844ad7ae163b95e17e0624 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Adult
146 rdf:type schema:DefinedTerm
147 N58253412b4c64f37a5f22d44b4be14ee schema:volumeNumber 15
148 rdf:type schema:PublicationVolume
149 N68a1135a4c614c5bbc486dedbfc205eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Vaginosis, Bacterial
151 rdf:type schema:DefinedTerm
152 N6945d7a409fb40d3bb19f878ab0ee8f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Anti-Bacterial Agents
154 rdf:type schema:DefinedTerm
155 N7eaae19f145441cd8177c6f40fc88fc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Middle Aged
157 rdf:type schema:DefinedTerm
158 N8ad16a88e67b41a4a03574723033127f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Double-Blind Method
160 rdf:type schema:DefinedTerm
161 N9705ac99117a4d4e819d39025aa36fac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Female
163 rdf:type schema:DefinedTerm
164 Nabc1676f6191440e9880174d1c49ba29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Poland
166 rdf:type schema:DefinedTerm
167 Nae3f7ad5189348a7a34d032aa2d90509 schema:name doi
168 schema:value 10.1186/s12905-015-0246-6
169 rdf:type schema:PropertyValue
170 Nb28cde1b42c846c892ddcb5828b163e2 rdf:first sg:person.01050221554.40
171 rdf:rest Nbda747ee65bd46d0b27cd4f970d64e55
172 Nbda747ee65bd46d0b27cd4f970d64e55 rdf:first sg:person.0762122263.14
173 rdf:rest N42655da94d7040bcbe4a86306f0439f9
174 Nde0ddf1f094346d9840e6b0596d1ef49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Humans
176 rdf:type schema:DefinedTerm
177 Nde7bfab0411043f890f8a408bd56ba7f rdf:first sg:person.01116334754.36
178 rdf:rest N2f60805c95434e3da9da79be6af7fa96
179 Ne540c27602b2478489550d5d293289d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Dietary Supplements
181 rdf:type schema:DefinedTerm
182 Neb2a7b8b7367479a9424ec63cf2a06f9 rdf:first sg:person.01013146401.27
183 rdf:rest rdf:nil
184 Nf3c97ab4891c48b99fc08e3825d1faa7 schema:name pubmed_id
185 schema:value 26635090
186 rdf:type schema:PropertyValue
187 Nf5c649e594fd4cd6951772844f5f4940 rdf:first sg:person.0617271731.33
188 rdf:rest Neb2a7b8b7367479a9424ec63cf2a06f9
189 Nf92a59386b4244f6b38c3ce5697d3e92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Probiotics
191 rdf:type schema:DefinedTerm
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
196 schema:name Clinical Sciences
197 rdf:type schema:DefinedTerm
198 sg:journal.1028438 schema:issn 1472-6874
199 schema:name BMC Women's Health
200 schema:publisher Springer Nature
201 rdf:type schema:Periodical
202 sg:person.01013146401.27 schema:affiliation grid-institutes:grid.5522.0
203 schema:familyName Strus
204 schema:givenName Magdalena
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013146401.27
206 rdf:type schema:Person
207 sg:person.01050221554.40 schema:affiliation grid-institutes:grid.450925.f
208 schema:familyName Adamski
209 schema:givenName Paweł
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050221554.40
211 rdf:type schema:Person
212 sg:person.01116334754.36 schema:affiliation grid-institutes:grid.5522.0
213 schema:familyName Heczko
214 schema:givenName Piotr B.
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116334754.36
216 rdf:type schema:Person
217 sg:person.01211122374.17 schema:affiliation grid-institutes:grid.5522.0
218 schema:familyName Tomusiak
219 schema:givenName Anna
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211122374.17
221 rdf:type schema:Person
222 sg:person.01274562631.03 schema:affiliation grid-institutes:grid.460350.4
223 schema:familyName Stefański
224 schema:givenName Grzegorz
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274562631.03
226 rdf:type schema:Person
227 sg:person.016617457130.93 schema:affiliation grid-institutes:grid.460350.4
228 schema:familyName Mikołajczyk-Cichońska
229 schema:givenName Aleksandra
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016617457130.93
231 rdf:type schema:Person
232 sg:person.0617271731.33 schema:affiliation grid-institutes:grid.460350.4
233 schema:familyName Suda-Szczurek
234 schema:givenName Magdalena
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617271731.33
236 rdf:type schema:Person
237 sg:person.0762122263.14 schema:affiliation grid-institutes:grid.418838.e
238 schema:familyName Jakimiuk
239 schema:givenName Artur J.
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762122263.14
241 rdf:type schema:Person
242 sg:pub.10.1007/s00404-014-3525-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015118061
243 https://doi.org/10.1007/s00404-014-3525-9
244 rdf:type schema:CreativeWork
245 sg:pub.10.1177/1933719111418379 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064079117
246 https://doi.org/10.1177/1933719111418379
247 rdf:type schema:CreativeWork
248 sg:pub.10.1186/1472-6874-8-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005792714
249 https://doi.org/10.1186/1472-6874-8-3
250 rdf:type schema:CreativeWork
251 grid-institutes:grid.418838.e schema:alternateName Department of Reproductive Health Research Institute of Mother and Child, Warsaw, Poland
252 schema:name Clinical Department of Obstetrics and Gynecology, Central Clinical Hospital of Ministry of Interior and Administration, Warsaw, Poland
253 Department of Reproductive Health Research Institute of Mother and Child, Warsaw, Poland
254 rdf:type schema:Organization
255 grid-institutes:grid.450925.f schema:alternateName Institute of Nature Conservation, Polish Academy of Sciences, Krakow, Poland
256 schema:name Institute of Nature Conservation, Polish Academy of Sciences, Krakow, Poland
257 rdf:type schema:Organization
258 grid-institutes:grid.460350.4 schema:alternateName IBSS BIOMED S.A, Krakow, Poland
259 schema:name IBSS BIOMED S.A, Krakow, Poland
260 rdf:type schema:Organization
261 grid-institutes:grid.5522.0 schema:alternateName Chair of Microbiology, Jagiellonian University Medical College, Krakow, Poland
262 schema:name Chair of Microbiology, Jagiellonian University Medical College, Krakow, Poland
263 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...